a:1:{s:5:"en_US";s:40:"Respiratory Diseases, University of Bari";}.
.
Acta Biomed. 2021 Jul 1;92(3):e2021165. doi: 10.23750/abm.v92i3.9909.
To date, there is still a lack of unanimity regarding the definition of exacerbation of asthma and COPD and about objective measurements in the currently used criteria. The aim of our study was to conduct a survey among general practitioners (GPs) and pulmonologists regarding the clinical criteria arbitrarily considered as important to start a course of systemic corticoids and/or antibiotics in asthma and COPD. We conducted a survey enrolling 50 general practitioners (GPs) and 50 pulmonologists, that evaluated the clinical criteria arbitrated as essential to start a course of systemic corticosteroids or antibiotics during asthma and/or COPD exacerbations. Our results demonstrated incongruities between GPs and pulmonologist and within the same professional category concerning systemic corticosteroids. Conversely, we showed higher consensus between and within the groups about criteria to prescribe antibiotics.
迄今为止,关于哮喘和 COPD 恶化的定义以及目前使用的标准中的客观测量方法仍缺乏一致性。我们的研究目的是在全科医生和肺科医生中就开始使用全身性皮质激素和/或抗生素治疗哮喘和 COPD 时任意认为重要的临床标准进行调查。我们进行了一项调查,共纳入 50 名全科医生和 50 名肺科医生,评估了在哮喘和/或 COPD 恶化期间开始全身性皮质激素或抗生素治疗的临床标准。我们的结果表明,全科医生和肺科医生之间以及同一专业类别内部在全身性皮质激素方面存在不一致性。相反,我们表明,关于使用抗生素的标准,两组之间和组内的一致性更高。